{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-22-000029","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2022-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.555393+00:00","generated_at":"2026-06-24T01:17:17.589207+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Landec reports Q4 net loss $35.9M, announces CEO change and rebranding","bullets":["Lifecore segment Q4 revenue $27.6M (+6.9% YoY), adjusted EBITDA $8.9M (+15.9%).","Consolidated Q4 net loss $35.9M includes $27M non-cash impairment on avocado business.","Full-year Lifecore revenue $109.3M (+11.5%), adjusted EBITDA $28.9M (+17.9%).","CEO Albert Bolles transitions to President of Curation Foods; James G. Hall named new CEO.","Plans to rebrand as Lifecore Biomedical, new ticker LFCR; four directors to step down at 2023 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-22-000029","json":"https://secwatch.observer/filing/0001005286-22-000029.json","markdown":"https://secwatch.observer/filing/0001005286-22-000029.md","text":"https://secwatch.observer/filing/0001005286-22-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/lndc-20220808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:17:17.589207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13e6df73d5","claim":"Albert Bolles resigned as Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"In accordance with the Separation Agreement, Dr. Bolles resigned as the Company’s Chief Executive Officer and as a director of the Board of Directors of the Company (the “Board), effective immediately, to transition to serve as President of Curation Foods, Inc., a wholly owned subsidiary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"51f1d5f1c0","claim":"Deborah Carosella departed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Deborah Carosella and Tonia Pankopf notified the Company that they each intend to resign as directors of the Board effective as of the 2023 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7468098228","claim":"James G. Hall was appointed as Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On August 10, 2022, the Board appointed James G. Hall as the Company’s Chief Executive Officer and as a director of the Board, succeeding Dr. Albert Bolles, to serve in such capacities until his successor is duly elected and qualified or until his earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"86c8fccd21","claim":"Andrew Powell departed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Andrew Powell, and Catherine A. Sohn, Pharm D. notified the Company that they have each elected not to stand for re-election to serve as directors of the Board at the Company’s 2023 annual stockholder meeting (the “ 2023 Annual Meeting ”)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8b0ed906dc","claim":"Tonia Pankopf departed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Deborah Carosella and Tonia Pankopf notified the Company that they each intend to resign as directors of the Board effective as of the 2023 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"dc7be2d885","claim":"Catherine A. Sohn departed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Andrew Powell, and Catherine A. Sohn, Pharm D. notified the Company that they have each elected not to stand for re-election to serve as directors of the Board at the Company’s 2023 annual stockholder meeting (the “ 2023 Annual Meeting ”)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}